loading
Precedente Chiudi:
$2.94
Aprire:
$2.89
Volume 24 ore:
10,364
Relative Volume:
0.02
Capitalizzazione di mercato:
$3.44M
Reddito:
$4.96M
Utile/perdita netta:
$-6.82M
Rapporto P/E:
-0.0436
EPS:
-65.4
Flusso di cassa netto:
$-6.64M
1 W Prestazione:
-5.00%
1M Prestazione:
-7.17%
6M Prestazione:
-54.65%
1 anno Prestazione:
-65.16%
Intervallo 1D:
Value
$2.85
$2.9882
Intervallo di 1 settimana:
Value
$2.66
$3.18
Portata 52W:
Value
$2.414
$15.70

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Name
Nome
Inmed Pharmaceuticals Inc
Name
Telefono
(604) 669-7207
Name
Indirizzo
1445-885 WEST GEORGIA ST., VANCOUVER
Name
Dipendente
13
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
INM's Discussions on Twitter

Confronta INM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
INM
Inmed Pharmaceuticals Inc
2.85 3.44M 4.96M -6.82M -6.64M -65.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
170.53 76.36B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.58 47.84B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.84 47.05B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.00 18.33B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.28 13.96B 612.78M -86.37M -62.91M -0.87

Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie

pulisher
Feb 18, 2025

InMed Pharmaceuticals Struggles with Losses Amid Revenue Decline - MSN

Feb 18, 2025
pulisher
Feb 15, 2025

InMed Pharmaceuticals Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

InMed Pharmaceuticals Board Reshuffle After Director Resignation - TipRanks

Feb 14, 2025
pulisher
Feb 13, 2025

InMed Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

Feb 13, 2025
pulisher
Feb 12, 2025

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Yahoo Finance

Feb 12, 2025
pulisher
Feb 12, 2025

InMed Pharmaceuticals Inc. (INM) reports earnings - Quartz

Feb 12, 2025
pulisher
Feb 12, 2025

InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

InMed's Mixed Q2 Results Reveal Hidden Gem: Subsidiary Turns 189% Profit as Pipeline Advances - StockTitan

Feb 12, 2025
pulisher
Feb 06, 2025

InMed Advances INM-089 for Dry AMD Treatment with New Intravitreal Formulation - TipRanks

Feb 06, 2025
pulisher
Feb 04, 2025

Inmed selects IVT formulation of INM-089 for dry AMD - BioWorld Online

Feb 04, 2025
pulisher
Feb 03, 2025

InMed advances AMD treatment with promising IVT drug formulation - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Revolutionary Eye Drug INM-089 Achieves 10X Therapeutic Levels in Macular Degeneration Treatment - StockTitan

Feb 03, 2025
pulisher
Jan 24, 2025

Inmed Pharmaceuticals Inc (INM-Q) QuotePress Release - The Globe and Mail

Jan 24, 2025
pulisher
Jan 24, 2025

InMed Pharmaceuticals (NASDAQ: INM) Secures International Patent for Novel Compounds - Defense World

Jan 24, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals Secures Key Patent for Cannabinoid Analogs - TipRanks

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals secures international patent - Investing.com India

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Secures Breakthrough 20-Year Patent in Mexico for Novel Cannabinoid Compounds - StockTitan

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals (NASDAQ: INM) Announces Positive Results from INM-901 Alzheimer’s Disease Study - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

InMed Hails Alzheimer's Study, Stocks Shoot Higher - Baystreet.ca

Jan 21, 2025
pulisher
Jan 21, 2025

InMed announces ‘positive’ results from in vivo preclinical Alzheimer’s study - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

InMed’s INM-901 Shows Promising Results in Preclinical Alzheimer’s Study - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile

Jan 21, 2025
pulisher
Jan 04, 2025

SABBY MANAGEMENT, LLC Acquires Shares in InMed Pharmaceuticals I - GuruFocus.com

Jan 04, 2025
pulisher
Dec 21, 2024

InMed Pharmaceuticals Inc. Holds 2024 Annual General Meeting – Elects Directors and Appoints Auditor - Defense World

Dec 21, 2024
pulisher
Dec 18, 2024

InMed Pharmaceuticals Director Faces Resignation After Shareholder Vote at Annual Meeting - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

InMed Announces Results of 2024 Annual General Meeting - Newsfile

Dec 18, 2024
pulisher
Dec 18, 2024

InMed Pharmaceuticals Inc. announced that it expects to receive CAD 10 million in funding - Marketscreener.com

Dec 18, 2024
pulisher
Dec 17, 2024

InMed Enters Into Standby Equity Purchase Agreement - Newsfile

Dec 17, 2024
pulisher
Dec 17, 2024

Head-To-Head Review: InMed Pharmaceuticals (NASDAQ:INM) & Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

InMed Pharmaceuticals Secures $10M Equity Purchase Agreement in Strategic Financing Move - StockTitan

Dec 17, 2024
pulisher
Dec 17, 2024

InMed Pharmaceuticals (TSE:IN) Trading Down 1.6% – Time to Sell? - Defense World

Dec 17, 2024
pulisher
Dec 05, 2024

InMed Pharmaceuticals (FRA:MWG) Altman Z-Score : -14.86 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 03, 2024

InMed Pharmaceuticals (FRA:MWG) Altman Z-Score : -14.90 (As of Dec. 03, 2024) - GuruFocus.com

Dec 03, 2024
pulisher
Nov 27, 2024

InMed Pharmaceuticals (FRA:MWG) Inventories, Finished Goods : €0.84 Mil (As of Sep. 2024) - GuruFocus.com

Nov 27, 2024
pulisher
Nov 27, 2024

InMed Pharmaceuticals (FRA:MWG) Shares Outstanding (EOP) : 0.67 Mil (As of Sep. 2024) - GuruFocus.com

Nov 27, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Total Liabilities : $2.07 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Debt-to-Equity : 0.13 (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) EBITDA : $-6.66 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Cash, Cash Equivalents, Marketa - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Growth Rank : 0 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Machinery, Furniture, Equipment : $0.04 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) 3-Year EPS without NRI Growth R - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Total Inventories : $1.22 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Net Income : $-6.82 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Inventory Turnover : 0.63 (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 26, 2024

INM (InMed Pharmaceuticals) Revenue per Share : $49.03 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Inmed Pharmaceuticals Inc Azioni (INM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$34.11
price down icon 0.64%
$11.31
price up icon 1.25%
$94.86
price up icon 1.11%
$9.33
price up icon 1.08%
$114.48
price down icon 3.57%
$131.28
price up icon 2.40%
Capitalizzazione:     |  Volume (24 ore):